Susquehanna International Group’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5M | Sell |
175,943
-17,120
| -9% | -$486K | ﹤0.01% | 1299 |
|
|
2025
Q1 | $5.7M | Buy |
193,063
+118,171
| +158% | +$3.49M | ﹤0.01% | 1089 |
|
|
2024
Q4 | $2.18M | Buy |
74,892
+41,679
| +125% | +$1.21M | ﹤0.01% | 1859 |
|
|
2024
Q3 | $1.53M | Sell |
33,213
-525
| -2% | -$24.1K | ﹤0.01% | 2172 |
|
|
2024
Q2 | $1.38M | Buy |
33,738
+20,017
| +146% | +$818K | ﹤0.01% | 2164 |
|
|
2024
Q1 | $350K | Sell |
13,721
-50,834
| -79% | -$1.3M | ﹤0.01% | 3978 |
|
|
2023
Q4 | $584K | Buy |
64,555
+7,675
| +13% | +$69.5K | ﹤0.01% | 3629 |
|
|
2023
Q3 | $363K | Sell |
56,880
-11,070
| -16% | -$70.6K | ﹤0.01% | 3837 |
|
|
2023
Q2 | $754K | Sell |
67,950
-44,362
| -39% | -$492K | ﹤0.01% | 3087 |
|
|
2023
Q1 | $1.72M | Buy |
112,312
+93,268
| +490% | +$1.43M | ﹤0.01% | 2145 |
|
|
2022
Q4 | $423K | Sell |
19,044
-41,500
| -69% | -$921K | ﹤0.01% | 3446 |
|
|
2022
Q3 | $989K | Buy |
60,544
+43,604
| +257% | +$712K | ﹤0.01% | 2555 |
|
|
2022
Q2 | $246K | Sell |
16,940
-3,406
| -17% | -$49.5K | ﹤0.01% | 4277 |
|
|
2022
Q1 | $376K | Sell |
20,346
-16,177
| -44% | -$299K | ﹤0.01% | 4076 |
|
|
2021
Q4 | $868K | Buy |
36,523
+9,609
| +36% | +$228K | ﹤0.01% | 3041 |
|
|
2021
Q3 | $663K | Buy |
26,914
+10,130
| +60% | +$250K | ﹤0.01% | 3317 |
|
|
2021
Q2 | $415K | Sell |
16,784
-17,286
| -51% | -$427K | ﹤0.01% | 4109 |
|
|
2021
Q1 | $743K | Buy |
+34,070
| New | +$743K | ﹤0.01% | 3364 |
|
|
2020
Q4 | – | Sell |
-17,995
| Closed | -$507K | – | 5223 |
|
|
2020
Q3 | $507K | Buy |
+17,995
| New | +$507K | ﹤0.01% | 3003 |
|